APGN — Apexigen Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro Cap

Annual balance sheet for Apexigen, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st
Period Length:	—	—	—
Source:	PROSPECTUS	PROSPECTUS	10-K
Standards:	USG	USG	USG
Status:	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	60.5	36.4	16.8
Prepaid Expenses
Total Other Current Assets
Total Current Assets	61.4	38	21.2
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	1.43	0.728	0.25
Other Long Term Assets
Total Assets	62.8	39.1	22.9
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	12.6	17	16.5
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	13.2	17.1	16.5
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	49.7	22	6.38
Total Liabilities & Shareholders' Equity	62.8	39.1	22.9
Total Common Shares Outstanding